These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 18791417)

  • 41. Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors.
    Lee J; Yamaguchi T; Abe A; Shizukuishi K; Uemura H; Miyagi E; Sakata K; Inoue T
    Radiat Med; 2004; 22(3):148-54. PubMed ID: 15287529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner.
    Sadick M; Schock D; Kraenzlin B; Gretz N; Schoenberg SO; Michaely HJ
    Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study.
    Kaji Y; Kuroda K; Maeda T; Kitamura Y; Fujiwara T; Matsuoka Y; Tamura M; Takei N; Matsuda T; Sugimura K
    J Magn Reson Imaging; 2007 Mar; 25(3):517-26. PubMed ID: 17279524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technical aspects on magnetic resonance imaging of the spine at 1.5 tesla.
    Holtås SL; Plewes DB; Simon JH; Ekholm S; Kido DK; Utz R
    Acta Radiol; 1987; 28(4):375-81. PubMed ID: 2958049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Proton spectroscopy findings of meningioma].
    Zhao JQ; Liang BL; Shen J; Tan XP; Zhang XH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):253-6. PubMed ID: 15807281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging protocol optimization for delineation of gross tumor volume in hypopharyngeal and laryngeal tumors.
    Verduijn GM; Bartels LW; Raaijmakers CP; Terhaard CH; Pameijer FA; van den Berg CA
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):630-6. PubMed ID: 19427562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-dimensional magnetic resonance observation of cartilage repair tissue (MOCART) score assessed with an isotropic three-dimensional true fast imaging with steady-state precession sequence at 3.0 Tesla.
    Welsch GH; Zak L; Mamisch TC; Resinger C; Marlovits S; Trattnig S
    Invest Radiol; 2009 Sep; 44(9):603-12. PubMed ID: 19692843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study.
    Mahon MM; deSouza NM; Dina R; Soutter WP; McIndoe GA; Williams AD; Cox IJ
    NMR Biomed; 2004 May; 17(3):144-53. PubMed ID: 15137039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
    Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
    Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparing real-world advantages for the clinical neuroradiologist between a high field (3 T), a phased array (1.5 T) vs. a single-channel 1.5-T MR system.
    Orbach DB; Wu C; Law M; Babb JS; Lee R; Padua A; Knopp EA
    J Magn Reson Imaging; 2006 Jul; 24(1):16-24. PubMed ID: 16767701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic resonance spectroscopy features of uterine leiomyomas.
    Celik O; Sarac K; Hascalik S; Alkan A; Mizrak B; Yologlu S
    Gynecol Obstet Invest; 2004; 58(4):194-201. PubMed ID: 15286450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
    Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
    Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.
    Thomassin-Naggara I; Daraï E; Cuenod CA; Rouzier R; Callard P; Bazot M
    J Magn Reson Imaging; 2008 Jul; 28(1):111-20. PubMed ID: 18581400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three-dimensional ultrashort echo time imaging of solid polymers on a 3-Tesla whole-body MRI scanner.
    Springer F; Martirosian P; Schwenzer NF; Szimtenings M; Kreisler P; Claussen CD; Schick F
    Invest Radiol; 2008 Nov; 43(11):802-8. PubMed ID: 18923260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
    Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
    Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update of prostate magnetic resonance imaging at 3 T.
    Kim CK; Park BK
    J Comput Assist Tomogr; 2008; 32(2):163-72. PubMed ID: 18379296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
    Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
    Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human breast lesions: characterization with proton MR spectroscopy.
    Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
    Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy.
    Lymer K; Haga K; Marshall I; Sailasuta N; Wardlaw J
    Magn Reson Imaging; 2007 Jun; 25(5):634-40. PubMed ID: 17540274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
    Fayad LM; Barker PB; Bluemke DA
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.